https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52348 Wed 28 Feb 2024 15:40:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54089 Wed 28 Feb 2024 15:38:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51944 MTC) was considered as the dependent variable; bioavailable As (BAs), total As (TAs), pH, organic carbon (OC), available phosphorus (AvP), and available iron (AvFe) were the predictor variables. LR performed better than RF and GBM in terms of accuracy, sensitivity, specificity, kappa, precision, log loss, F1score, and MCC. From the better-performing LR model, bioavailable As (BAs), TAs, AvFe, and OC were significant variables for grain As. From the partial dependence plots (PDP) and individual conditional expectation (ICE) of the LR model, 5.70 mg kg−1 was estimated to be the limit for BAs in soil.]]> Wed 28 Feb 2024 15:34:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53245 Wed 28 Feb 2024 15:32:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52663 Wed 28 Feb 2024 15:23:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52058 Wed 27 Sep 2023 15:29:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39569 Wed 27 Jul 2022 14:39:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50485 Wed 26 Jul 2023 19:04:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49639 Wed 24 May 2023 16:20:38 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48588 Wed 22 Mar 2023 08:32:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53568 Wed 17 Apr 2024 15:45:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51050 Wed 16 Aug 2023 12:22:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50691 Wed 15 May 2024 14:30:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47156 Public Health Consequences of E-Cigarettes from the United States NASEM was accepted as reflective of evidence to mid-2017. A search for papers subsequently published in peer-reviewed journals was conducted in August 2018. A small number of robust and important papers published until March 2019 were also identified and included. Groups identified studies that extended, modified or contradicted the NASEM report. A total of 3793 papers were identified and reviewed, with summaries and draft position statements developed and presented to TSANZ membership in April 2019. After feedback from members and external reviewers, a collection of position statements was finalized in December 2019. EC have adverse lung effects and harmful effects of long-term use are unknown. EC are unsuitable consumer products for recreational use, part-substitution for smoking or long-term exclusive use by former smokers. Smokers who require support to quit smoking should be directed towards approved medication in conjunction with behavioural support as having the strongest evidence for efficacy and safety. No specific EC product can be recommended as effective and safe for smoking cessation. Smoking cessation claims in relation to EC should be assessed by established regulators.]]> Wed 14 Dec 2022 15:34:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45395 Wed 13 Mar 2024 19:07:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49511 Wed 13 Mar 2024 09:24:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49415 Wed 13 Mar 2024 08:57:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53953 Wed 13 Mar 2024 07:48:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36258 Wed 09 Feb 2022 15:58:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49874 Wed 07 Jun 2023 18:21:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48980 Wed 06 Mar 2024 14:15:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44010 Wed 05 Oct 2022 15:12:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50146 Wed 05 Jul 2023 13:57:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49018 Wed 03 May 2023 12:31:08 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49014 Wed 03 May 2023 12:24:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36262 Wed 02 Mar 2022 14:23:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38624 Wed 01 Dec 2021 14:17:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51269 Tue 29 Aug 2023 15:41:29 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39872 a deliberate, iterative and data-driven process to improve a health intervention and/or its implementation to meet stakeholder-defined public health impacts within resource constraints. This study aimed to identify frameworks used to optimise the impact of health interventions and/or their implementation, and characterise the key concepts, steps or processes of identified frameworks. Methods: A scoping review of MEDLINE, CINAL, PsycINFO, and ProQuest Nursing & Allied Health Source databases was undertaken. Two reviewers independently coded the key concepts, steps or processes involved in each frameworks, and identified if it was a framework aimed to optimise interventions or their implementation. Two review authors then identified the common steps across included frameworks. Results: Twenty optimisation frameworks were identified. Eight frameworks were for optimising interventions, 11 for optimising implementation and one covered both intervention and implementation optimisation. The mean number of steps within the frameworks was six (range 3–9). Almost half (n = 8) could be classified as both linear and cyclic frameworks, indicating that some steps may occur multiple times in a single framework. Two meta- frameworks are proposed, one for intervention optimisation and one for implementation strategy optimisation. Steps for intervention optimisation are: Problem identification; Preparation; Theoretical/Literature base; Pilot/ Feasibility testing; Optimisation; Evaluation; and Long-term implementation. Steps for implementation strategy optimisation are: Problem identification; Collaborate; Plan/design; Pilot; Do/change; Study/evaluate/check; Act; Sustain/endure; and Disseminate/extend. Conclusions: This review provides a useful summary of the common steps followed to optimise a public health intervention or its implementation according to established frameworks. Further opportunities to study and/or validate such frameworks and their impact on improving outcomes exist.]]> Tue 28 Jun 2022 14:33:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54533 Tue 27 Feb 2024 19:51:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36178 Tue 25 Feb 2020 09:45:32 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42453 Tue 23 Aug 2022 12:32:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51129 Tue 22 Aug 2023 15:52:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37369 Tue 20 Oct 2020 09:00:32 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44590 Tue 18 Oct 2022 09:04:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38594 Trichomonas vaginalis, bacterial vaginosis and possibly genital ulcer disease. For herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, human immunodeficiency virus and candidiasis, the evidence is mixed. Male partner MC did not reduce risk of gonorrhea, Mycoplasma genitalium, dysuria or vaginal discharge in women. Conclusion: MC reduces risk of oncogenic HPV genotypes, cervical cancer, T. vaginalis, bacterial vaginosis and possibly genital ulcer disease in women. The reduction in risk of these STIs and cervical cancer adds to the data supporting global efforts to deploy MC as a health-promoting and life-saving public health measure and supplements other STI prevention strategies.]]> Tue 16 Nov 2021 15:04:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55144 Tue 16 Apr 2024 09:45:40 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45060 Tue 14 Nov 2023 14:40:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43062 Tue 13 Sep 2022 08:32:19 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47035 Tue 13 Dec 2022 14:15:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47020 Tue 13 Dec 2022 12:44:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34415 Tue 03 Sep 2019 18:11:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32055 Tue 03 Sep 2019 17:54:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50044 Thu 29 Jun 2023 14:38:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50038 Thu 29 Jun 2023 14:17:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45289 Thu 27 Oct 2022 13:47:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45334 Thu 27 Oct 2022 10:22:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35784 Thu 21 Nov 2019 15:51:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36626 Thu 18 Jun 2020 17:00:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38648 Thu 18 Aug 2022 14:52:06 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36615 Thu 14 Apr 2022 11:05:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37852 Thu 13 Jan 2022 10:30:47 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37423 60) that guide design and evaluation of implementation and scale-up processes. Therefore, we sought to recommend conceptual frameworks that can be used to design, inform, and evaluate implementation of physical activity (PA) and nutrition interventions at different stages of the program life cycle. We also sought to recommend a minimum data set of implementation outcome and determinant variables (indicators) as well as measures and tools deemed most relevant for PA and nutrition researchers. Methods: We adopted a five-round modified Delphi methodology. For rounds 1, 2, and 3 we administered online surveys to PA and nutrition implementation scientists to generate a rank order list of most commonly used; i) implementation and scale-up frameworks, ii) implementation indicators, and iii) implementation and scale-up measures and tools. Measures and tools were excluded after round 2 as input from participants was very limited. For rounds 4 and 5, we conducted two in-person meetings with an expert group to create a shortlist of implementation and scale-up frameworks, identify a minimum data set of indicators and to discuss application and relevance of frameworks and indicators to the field of PA and nutrition. Results: The two most commonly referenced implementation frameworks were the Framework for Effective Implementation and the Consolidated Framework for Implementation Research. We provide the 25 most highly ranked implementation indicators reported by those who participated in rounds 1–3 of the survey. From these, the expert group created a recommended minimum data set of implementation determinants (n = 10) and implementation outcomes (n = 5) and reconciled differences in commonly used terms and definitions. Conclusions: Researchers are confronted with myriad options when conducting implementation and scale-up evaluations. Thus, we identified and prioritized a list of frameworks and a minimum data set of indicators that have potential to improve the quality and consistency of evaluating implementation and scale-up of PA and nutrition interventions. Advancing our science is predicated upon increased efforts to develop a common ‘language’ and adaptable measures and tools.]]> Thu 12 Nov 2020 18:13:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37412 Thu 12 Nov 2020 17:03:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47985 Thu 09 May 2024 14:33:46 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38650 Thu 09 Dec 2021 11:39:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50609 Mon 31 Jul 2023 12:58:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49678 Mon 29 May 2023 09:37:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37943 Mon 29 Jan 2024 18:44:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39018 2DS₂-VA scheme, were calculated. Factors associated with AF were assessed using logistic regression. Results: From 2000 to 2015, a total of 1827 women with AF were identified. AF prevalence increased every year as women aged from 2.71% (95% CI 1.62%–3.80%) in 2000 among women aged 74–79 years to 24.83% (95% CI = 23.23%–26.44%) in 2015 among women aged 89–94 years. The incidence proportion remained constant (between 3% and 5%) throughout the study period. Sedentary lifestyle (OR = 1.24, 95% CI = 1.04–1.49), hypertension (OR = 1.24, 95% CI = 1.09–1.42), arthritis (OR = 1.24, 95% CI = 1.09–1.41), heart attack (OR = 1.62, 95% CI = 1.18–2.24), and angina (OR = 1.39, 95% CI = 1.14–1.70) were independently associated with AF. Mean CHA₂DS₂-VA score for women with AF was 3.43 (SD ± 1.23). Conclusions: The prevalence of AF reported in Australian women is among the highest compared to previous estimations from other countries and regions. According to the findings, about one in four women over the age of 90 years had AF. These women were also at high risk of stroke. This has significant public health implications especially with changing demographics of increase in the aging population. Further research is required on understanding how women with AF are treated in Australia and their health outcomes.]]> Mon 29 Jan 2024 17:43:06 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46627 Mon 28 Nov 2022 13:38:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51235 Mon 28 Aug 2023 12:19:57 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53409 Mon 27 Nov 2023 09:27:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36159 Mon 26 Oct 2020 12:03:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35536 Mon 26 Aug 2019 12:12:04 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44733 Mon 24 Oct 2022 08:28:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52698 Mon 23 Oct 2023 14:05:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36661 Mon 22 Jun 2020 16:39:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53941 Mon 22 Jan 2024 16:56:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51780 Mon 18 Sep 2023 15:11:40 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44560 Mon 17 Oct 2022 10:13:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41862 Mon 15 Aug 2022 10:35:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51320 Mon 13 May 2024 15:46:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52293 Mon 13 May 2024 13:01:48 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49748 Mon 13 May 2024 11:43:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35887 Mon 13 Jan 2020 17:05:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54183 Mon 12 Feb 2024 13:47:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44219 Mon 10 Oct 2022 16:59:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44216 Mon 10 Oct 2022 16:59:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44208 Mon 10 Oct 2022 15:49:45 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44179 Mon 10 Oct 2022 10:34:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44157 Mindframe media guidelines for reporting on suicide. Results: A total of 17 documents across 12 media agencies were identified. Ten of the 12 agencies provided specific advice about the reporting of suicide, with all agencies that issue codes of practice or editorial policies including between two and 10 recommendations aligned with the Mindframe guidelines. Conclusions: While the results of this study are positive, significant variation between media agencies shows that there are opportunities to enhance adoption and implementation of evidence-informed guidance for media professionals in Australia. So what?: With over 3000 people dying by suicide and over 60 000 people attempting suicide each year in Australia, the prevention of suicide remains a key public health priority requiring a multi-sector and health-in-all-policies approach. This study reveals that there is a strong platform for ongoing collaboration with the Australian media to ensure safe and sensitive coverage of suicide.]]> Mon 10 Oct 2022 09:31:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50827 Mon 07 Aug 2023 14:42:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49927 Mon 06 May 2024 15:16:01 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46866 Mon 05 Dec 2022 08:46:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39204 Fri 27 May 2022 09:45:33 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43869 Fri 25 Nov 2022 15:37:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55399 Fri 24 May 2024 11:50:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48627 Fri 24 Mar 2023 09:39:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47452 Fri 20 Jan 2023 16:47:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49955 Fri 16 Jun 2023 15:20:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51720 Fri 15 Sep 2023 17:53:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54842 Fri 15 Mar 2024 14:38:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54837 Fri 15 Mar 2024 11:55:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48916 Fri 14 Apr 2023 16:14:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47294 Fri 13 Jan 2023 10:45:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38570 Fri 12 Nov 2021 12:46:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49361 Fri 12 May 2023 12:35:08 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49192 Fri 05 May 2023 15:51:19 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50754 Fri 04 Aug 2023 11:34:37 AEST ]]>